PCP
ACHN

Proficio Capital Partners’s Achillion Pharmaceuticals ACHN Stock Holding History

Proficio Capital Partners’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,525
Closed -$4K – 1905
2019
Q2 		$4K Hold
1,525
– – ﹤0.01% 1347
2019
Q1 		$5K Buy
+1,525
New +$3.75K ﹤0.01% 1137

Other funds holding ACHN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Proficio Capital Partners's ACHN Position: Q3 2019 in Review

Proficio Capital Partners sold out of Achillion Pharmaceuticals (ACHN) in Q3 2019, closing a stake of 1,525 shares — an estimated $4K sold.

Proficio Capital Partners first reported a position in ACHN in Q1 2019 and held it in 2 quarters. The position peaked at $5K in Q1 2019. 122 funds tracked by Wall St. Rank hold ACHN as of Q3 2019.

  • Proficio Capital Partners reported no remaining Achillion Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Proficio Capital Partners sold 1,525 Achillion Pharmaceuticals shares in Q3 2019, an estimated $4K.
  • Proficio Capital Partners first reported a position in Achillion Pharmaceuticals in Q1 2019 and held it in 2 quarters.
  • Proficio Capital Partners's Achillion Pharmaceuticals position peaked at $5K in Q1 2019.
  • 122 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q3 2019.

Based on Proficio Capital Partners's 13F filing for Q3 2019, filed 13 Nov 2019.